Editorial: FDA should press on for stronger OTC labels

The Journal and Constitution urged the FDA in an editorial to proceed with a proposal to require stronger warning labels on aspirin and similar over-the-counter painkillers. The editorial said a federal agency can do only so much, so it should be left to consumers to gauge their own use of the drugs.

View Full Article in:

Journal and Constitution (Atlanta) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT